A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds…
The post Prevalence and timing of au…
Prevalence and timing of authorized generics in the US market Read Post »
SIGNIFOR LAR KIT (pasireotide pamoate) Recordati rare Patent: 8,822,637 Expiration: Aug 6, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for …
Drug Patent Expirations for the Week of August 6, 2023 Read Post »
Pharmaceutical drug patents enable branded drug companies to prevent market entry by competitors until the patents expire. The term of drug patents varies. The basic term for a patent is…
The post Future drug patent expirations by year appeared first o…
A recent update from Foley & Lardner attorney Courtenay C. Brinckerhoff discusses trends in Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings involving Orange Book and biologic patents, based…
The post Insights into Shifting Dynamics: O…
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends Read Post »
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Bulgaria? Read Post »
Annual Drug Patent Expirations for SIGNIFOR+LAR+KIT Signifor Lar Kit is a drug marketed by Recordati Rare and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT …
New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT Read Post »
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA…
New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Colomb…
Which pharmaceutical drugs have the most drug patents in Colombia? Read Post »
In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases…
The post The Evolution of Reverse Paym…
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fourteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared …
Get new actionable insights and updates from BiotechBlog
